SecurityINSM / Insmed, Inc. (457669307)
President & CEOLewis William
IndustryPharmaceutical Preparations
Institutional Owners142
Institutional Shares77,354,831 - 100.41%
Institutional Value$ 3,637,609,000 USD

Institutional Stock Ownership and Shareholders

Insmed, Inc. (NASDAQ:INSM) has 142 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 77,354,831 shares. Largest shareholders include Price T Rowe Associates Inc /md/, BlackRock Inc., Henderson Group Plc, Palo Alto Investors, LLC, Vanguard Group Inc, State Street Corp, Orbimed Advisors Llc, Janus Capital Management Llc, BlackRock Fund Advisors, and Redmile Group, LLC.
Insmed, Inc. (NASDAQ:INSM) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-07-17 13F-HR FOX RUN MANAGEMENT, L.L.C. 19,894 470
2018-08-10 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 10,775 8,861 -17.76 243 210 -13.58
2018-08-14 13F-HR MORGAN STANLEY 670,020 705,283 5.26 15,089 16,681 10.55
2018-08-14 13F-HR NEXTHERA CAPITAL LP 918,523 646,863 -29.58 20,685 15,298 -26.04
2018-08-14 13F-HR Squarepoint Ops LLC 0 17,156 0 406
2018-08-14 13F-HR Foresite Capital Management Iv, Llc 1,799,225 1,800,587 0.08 40,519 42,584 5.10
2018-08-08 13F-HR US BANCORP \DE\ 681 626 -8.08 15 15 0.00
2017-05-16 13F-HR JANUS CAPITAL MANAGEMENT LLC 2,855,576 2,809,457 -1.62 37,784 49,191 30.19
2018-08-13 13F-HR UNIVERSITY OF NOTRE DAME DU LAC 90,753 101,063 11.36 2,044 2,390 16.93
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 56,876 57,033 0.28 1,281 1,349 5.31
2018-08-06 13F-HR Asymmetry Capital Management, L.P. 162,185 198,801 22.58 3,652 4,702 28.75
2018-08-14 13F-HR LORD, ABBETT & CO. LLC 799,733 620,112 -22.46 18,010 14,666 -18.57
2018-08-13 13F-HR WOLVERINE TRADING, LLC Call 19,800 19,800 0.00 446 446 0.00
2018-08-14 13F-HR SECOR Capital Advisors, LP 16,649 22,607 35.79 375 535 42.67
2017-08-11 13F-HR FT Options LLC 8,475 17,958 111.89 148 308 108.11
2018-07-30 13F-HR SIMPLEX TRADING, LLC Call 1 369 36,800.00 0 872
2018-07-31 13F-HR EMERALD MUTUAL FUND ADVISERS TRUST 628,779 630,115 0.21 14,160 14,902 5.24
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 684 1,295 89.33 15 31 106.67
2018-08-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 82,100 85,900 4.63 1,849 2,032 9.90
2018-08-13 13F-HR GROUP ONE TRADING, L.P. Call 35,400 40,600 14.69 797 960 20.45
2018-08-10 13F-HR Pacad Investment Ltd. 0 5,100 0 122
2018-08-15 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 24,931 24,931 0.00 561,446 589,619 5.02
2018-08-10 13F-HR Quantitative Investment Management, LLC 18,600 439
2018-07-30 13F-HR SIMPLEX TRADING, LLC Put 1 758 75,700.00 0 1,792
2018-08-14 13F-HR UBS Group AG 117,567 18,052 -84.65 2,647 427 -83.87
2018-07-16 13F-HR FRANKLIN STREET ADVISORS INC /NC 15,700 16,300 3.82 354 385 8.76
2018-08-08 13F-HR AMERICAN INTERNATIONAL GROUP INC 48,909 49,888 2.00 1,101 1,180 7.18
2018-08-13 13F-HR PICTET ASSET MANAGEMENT LTD 65,100 0 -100.00 1,466 0 -100.00
2018-08-13 13F-HR Ameritas Investment Partners, Inc. 6,347 6,347 0.00 143 150 4.90
2017-02-10 13F-HR BlackRock Fund Advisors 2,392,925 2,705,488 13.06 34,745 35,794 3.02
2018-08-14 13F-HR Adage Capital Partners GP LLC 890,000 1,250,000 40.45 20,043 29,563 47.50
2018-08-06 13F-HR MACKAY SHIELDS LLC 28,908 28,908 0.00 651 684 5.07
2018-08-07 13F-HR Bellevue Group AG 334,489 424,051 26.78 7,533 10,029 33.13
2018-08-14 13F-HR Dynamic Technology Lab Private Ltd 8,466 200
2018-08-14 13F-HR TUDOR INVESTMENT CORP ET AL 15,066 0 -100.00 339 0 -100.00
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 201,700 145,200 -28.01 4,542 3,434 -24.39
2018-08-14 13F-HR BARCLAYS PLC Call 100 0 -100.00 2 0 -100.00
2018-08-14 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 87,338 103,385 18.37 1,967 2,445 24.30
2018-02-09 13F-HR RidgeWorth Capital Management LLC 0 11,494 0 358
2018-08-09 13F-HR Swiss National Bank 126,900 133,400 5.12 2,858 3,155 10.39
2018-08-13 13F-HR ALLIANCEBERNSTEIN L.P. 181,800 114,000 -37.29 4,094 2,696 -34.15
2018-08-14 13F-HR Candriam Luxembourg S.C.A. 0 95,067 0 2,248
2018-08-10 13F-HR Summit Trail Advisors, Llc 12,178 0 -100.00 250 0 -100.00
2018-07-31 13F-HR LOS ANGELES CAPITAL MANAGEMENT & EQUITY RESEARCH INC 74,280 82,680 11.31 1,673 1,955 16.86
2018-08-13 13F-HR Quantbot Technologies LP 4,841 0 -100.00 109 0 -100.00
2018-08-02 13F-HR/A ALPS ADVISORS INC 102,752 110,402 7.45 2,314 2,611 12.83
2018-08-10 13F-HR Legal & General Group Plc 29,657 28,073 -5.34 668 664 -0.60
2018-08-14 13F-HR QS Investors, LLC 71,511 69,831 -2.35 1,610 1,652 2.61
2018-08-14 13F-HR JP Morgan Chase & Co Put 40,000 0 -100.00 901 0 -100.00
2018-08-14 13F-HR CREDIT SUISSE AG/ 82,153 65,219 -20.61 1,850 1,543 -16.59
2018-08-14 13F-HR BOOTHBAY FUND MANAGEMENT, LLC Call 583 583 0.00 1,313 1,379 5.03
2018-07-30 13F-HR Daiwa Securities Group Inc. 423 423 0.00 10 10 0.00
2018-08-14 13F-HR Wellington Management Group LLP 137,340 0 -100.00 3,093 0 -100.00
2018-08-14 13F-HR Palo Alto Investors, LLC 7,159,590 7,236,583 1.08 161,234 171,145 6.15
2018-08-10 13F-HR Cutler Group LP 0 1,300 0 30
2018-08-10 13F-HR CITIGROUP INC 72,886 60,608 -16.85 1,641 1,433 -12.68
2018-08-03 13F-HR CAM Group Holding A/S 372,662 410,954 10.28 8,392 9,719 15.81
2018-08-09 13F-HR CHARTWELL INVESTMENT PARTNERS, LLC 52,628 87,298 65.88 1,185 2,065 74.26
2017-02-10 13F-HR BlackRock Group LTD 26,681 29,032 8.81 387 384 -0.78
2018-08-15 13F-HR GLENMEDE TRUST CO NA 276 7
2018-08-14 13F-HR BARCLAYS PLC 39,665 29,986 -24.40 894 709 -20.69
2018-08-14 13F-HR JP Morgan Chase & Co Call 40,000 0 -100.00 901 0 -100.00
2018-08-14 13F-HR Jefferies Group LLC 8,965 0 -100.00 202 0 -100.00
2018-08-14 13F-HR Man Group plc 52,485 1,242
2018-08-14 13F-HR Omega Advisors Inc. 98,000 95,000 -3.06 2,207 2,247 1.81
2018-08-14 13F-HR Weiss Multi-Strategy Advisers LLC 70,000 78,000 11.43 1,576 1,845 17.07
2018-08-10 13F-HR Cutler Group LP Put 0 3,500 0 17
2017-02-10 13F-HR BlackRock Japan Co. Ltd 91 0 -100.00 1 0 -100.00
2018-08-14 13F-HR MILLENNIUM MANAGEMENT LLC 0 11,639 0 275
2018-08-10 13F-HR CITIGROUP INC Call 7,300 300 -95.89 164 7 -95.73
2018-08-13 13F-HR WOLVERINE TRADING, LLC Put 42,000 42,000 0.00 946 946 0.00
2018-08-08 13F-HR Russell Investments Group, Ltd. 26,529 26,744 0.81 598 633 5.85
2018-08-14 13F-HR TEACHERS ADVISORS INC 259,384 267,305 3.05 5,841 6,322 8.23
2018-07-27 13F-HR PIEDMONT INVESTMENT ADVISORS LLC 1,330 31
2018-08-14 13F-HR VANGUARD GROUP INC 6,428,289 6,648,576 3.43 144,764 157,238 8.62
2018-08-14 13F-HR HBK INVESTMENTS L P 98,252 12,300 -87.48 2,213 291 -86.85
2018-08-08 13F-HR AMERICAN CENTURY COMPANIES INC 0 128,116 0 3,030
2018-08-14 13F-HR Foresite Capital Management Iv, Llc Put 300,000 0 -100.00 6,800 0 -100.00
2017-02-10 13F-HR BlackRock Investment Management, LLC 235,774 235,336 -0.19 3,423 3,113 -9.06
2018-07-31 13F-HR EMERALD ADVISERS INC/PA 726,946 718,889 -1.11 16,371 17,002 3.85
2018-08-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 147,600 136,100 -7.79 3,324 3,219 -3.16
2018-08-03 13F-HR STATE OF WISCONSIN INVESTMENT BOARD 74,200 78,000 5.12 1,671 1,845 10.41
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 35,974 84,105 133.79 810 1,989 145.56
2018-08-14 13F-HR BARCLAYS PLC Put 100 0 -100.00 2 0 -100.00
2018-08-14 13F-HR AMERIPRISE FINANCIAL INC 322,588 366,630 13.65 7,266 8,671 19.34
2018-08-08 13F-HR Private Ocean, LLC 2,500 0 -100.00 56 0 -100.00
2018-08-14 13F-HR TWO SIGMA ADVISERS, LP 9,300 10,600 13.98 209 251 20.10
2018-07-25 13F-HR BNP PARIBAS ARBITRAGE, SA 16,243 4,273 -73.69 365,792 101,056 -72.37
2018-08-14 13F-HR Baker Brothers Advisors LP 700,000 700,000 0.00 15,764 16,555 5.02
2018-08-13 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 29,584 89,987 204.17 666 2,128 219.52
2018-08-14 13F-HR Sabby Management, LLC Put 543 1,661 205.89 1,223 3,928 221.18
2018-08-02 13F-HR RICE HALL JAMES & ASSOCIATES, LLC 261,712 283,184 8.20 5,894 6,697 13.62
2018-08-01 13F-HR FIRST MANHATTAN CO 25 25 0.00 0 0
2018-08-06 13F-HR TEACHER RETIREMENT SYSTEM OF TEXAS 16,103 15,527 -3.58 363 367 1.10
2018-08-13 13F-HR GROUP ONE TRADING, L.P. Put 49,200 44,500 -9.55 1,108 1,052 -5.05
2018-08-03 13F-HR SEI INVESTMENTS CO 14,919 14,196 -4.85 336 335 -0.30
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 731,229 772,956 5.71 16,467 18,280 11.01
2018-08-13 13F-HR Worth Venture Partners, LLC Put 11,700 94,000 703.42 26 217 734.62
2018-08-14 13F-HR Voya Investment Management LLC 798,615 1,053,468 31.91 17,985 24,914 38.53
2018-08-14 13F-HR ORBIMED ADVISORS LLC 2,927,891 2,927,891 0.00 65,936 69,245 5.02
2018-08-14 13F-HR BROWN BROTHERS HARRIMAN & CO 975 0 -100.00 22 0 -100.00
2018-08-13 13F-HR EARNEST PARTNERS LLC 1,130 1,130 0.00 25 27 8.00
2018-08-06 13F-HR RHUMBLINE ADVISERS 73,219 74,759 2.10 1,649 1,768 7.22
2018-08-14 13F-HR J. Goldman & Co LP 265,123 45,807 -82.72 5,971 1,083 -81.86
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 58,400 43,223 -25.99 1,315 1,023 -22.21
2018-08-07 13F-HR SG Americas Securities, LLC 5,138 4,480 -12.81 116 106 -8.62
2018-08-14 13F-HR STATE STREET CORP 3,461,180 2,977,862 -13.96 77,944 70,425 -9.65
2018-09-18 13F-HR/A NORTHERN TRUST CORP 957,164 987,228 3.14 21,555 23,348 8.32
2018-08-09 13F-HR/A Smith Asset Management Group LP 7,390 7,480 1.22 166 177 6.63
2018-08-14 13F-HR Rock Springs Capital Management LP 825,000 825,000 0.00 18,579 19,511 5.02
2018-08-03 13F-HR THOMPSON DAVIS & CO., INC. 500 500 0.00 11 12 9.09
2018-08-14 13F-HR J. Goldman & Co LP Call 0 90,000 0 2,129
2017-05-01 13F-HR Spot Trading L.L.C Call 20,000 350
2018-08-14 13F-HR Tower Research Capital LLC (TRC) 4,034 0 -100.00 91 0 -100.00
2018-08-14 13F-HR Invesco Ltd. 137,785 0 -100.00 3,103 0 -100.00
2018-08-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 244,311 226,482 -7.30 5,502 5,356 -2.65
2018-08-13 13F-HR WOLVERINE TRADING, LLC 25,807 25,807 0.00 581 581 0.00
2018-08-14 13F-HR PRICE T ROWE ASSOCIATES INC /MD/ 12,580,281 12,499,490 -0.64 283,308 295,613 4.34
2018-08-10 13F-HR HENDERSON GROUP PLC 6,246,342 7,454,938 19.35 140,668 176,309 25.34
2018-07-18 13F-HR AMALGAMATED BANK 10,181 11,699 14.91 229 277 20.96
2018-08-10 13F-HR VIRTUS ETF ADVISERS LLC 24,409 28,718 17.65 550 679 23.45
2018-08-14 13F-HR GUGGENHEIM CAPITAL LLC 103,962 0 -100.00 2,342 0 -100.00
2018-08-02 13F-HR PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 6,021 6,021 0.00 136 142 4.41
2018-08-16 13F-HR/A COWEN GROUP, INC. Put 39,100 0 -100.00 880 0 -100.00
2018-08-13 13F-HR ProShare Advisors LLC 45,207 42,289 -6.45 1,018 1,000 -1.77
2018-05-11 13F-HR CITIGROUP INC 65,397 72,886 11.45 2,039 1,641 -19.52
2018-08-14 13F-HR DLD Asset Management, LP Put 110,000 583,000 430.00 2,477 13,782 456.40
2018-08-14 13F-HR Parallax Volatility Advisers, L.P. Put 20,000 473
2018-08-20 13F-HR Winton Capital Group Ltd 21,256 9,534 -55.15 479 225 -53.03
2018-08-14 13F-HR DekaBank Deutsche Girozentrale 34,400 34,400 0.00 758 826 8.97
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 369,900 193,500 -47.69 8,330 4,576 -45.07
2018-08-03 13F-HR Seacrest Wealth Management, Llc 100 100 0.00 2 2 0.00
2018-08-09 13F-HR BlackRock Inc. 7,725,860 8,011,650 3.70 173,986 189,475 8.90
2018-08-15 13F-HR Metlife Investment Advisors, Llc 33,492 37,652 12.42 754 890 18.04
2018-08-14 13F-HR UBS ASSET MANAGEMENT AMERICAS INC 53,504 50,066 -6.43 1,204,911 1,184,062 -1.73
2018-07-11 13F-HR Xact Kapitalforvaltning AB 15,481 13,781 -10.98 349 326 -6.59
2018-08-14 13F-HR Parallax Volatility Advisers, L.P. Call 18,000 426
2018-08-14 13F-HR DEUTSCHE BANK AG\ 272,145 353,572 29.92 6,127 8,361 36.46
2018-08-13 13F-HR Allianz Asset Management AG 0 78,650 0 1,861
2018-08-14 13F-HR TWO SIGMA INVESTMENTS LLC 95,885 9,542 -90.05 2,159 226 -89.53
2018-08-14 13F-HR OBERWEIS ASSET MANAGEMENT INC/ 0 10,600 0 251
2018-08-06 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 35,620 38,450 7.94 802 909 13.34
2018-08-10 13F-HR UNITED SERVICES AUTOMOBILE ASSOCIATION 11,760 11,760 0.00 265 278 4.91
2018-07-25 13F-HR BNP PARIBAS ARBITRAGE, SA Put 10,500 0 -100.00 236,460 0 -100.00
2018-08-14 13F-HR PointState Capital LP 226,000 0 -100.00 5,090 0 -100.00
2018-08-14 13F-HR ADVENT CAPITAL MANAGEMENT /DE/ 50 0 -100.00 1 0 -100.00
2018-08-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 116,525 117,199 0.58 2,624 2,772 5.64
2018-07-31 13F-HR TD ASSET MANAGEMENT INC 259,895 265,695 2.23 5,853 6,284 7.36
2018-08-01 13F-HR SYNOVUS FINANCIAL CORP 50 50 0.00 1 1 0.00
2018-08-14 13F-HR MACQUARIE GROUP LTD 70,000 1,656
2018-08-15 13F-HR JANE STREET GROUP, LLC 13,464 0 -100.00 303 0 -100.00
2018-08-14 13F-HR/A CITADEL ADVISORS LLC Put 21,000 32,700 55.71 473 773 63.42
2018-08-14 13F-HR/A CITADEL ADVISORS LLC 0 222,388 0 5,260
2018-08-14 13F-HR Sabby Management, LLC 13,300 17,800 33.83 300 421 40.33
2018-08-06 13F-HR Zurcher Kantonalbank (Zurich Cantonalbank) 4,662 4,662 0.00 105 110 4.76
2018-05-11 13F-HR CITIGROUP INC Call 39,900 7,300 -81.70 1,244 164 -86.82
2018-07-17 13F-HR Gemmer Asset Management LLC 3 3 0.00 0 0
2018-08-14 13F-HR Clearbridge Investments, LLC 1,376 581 -57.78 31 14 -54.84
2018-08-02 13F-HR VICTORY CAPITAL MANAGEMENT INC 589,460 0 -100.00 13,274 0 -100.00
2018-07-18 13F-HR NISA INVESTMENT ADVISORS L.L.C. 450 650 44.44 10 15 50.00
2018-08-16 13F-HR/A COWEN GROUP, INC. 18,500 0 -100.00 417 0 -100.00
2018-08-13 13F-HR PRINCIPAL FINANCIAL GROUP INC 155,661 149,274 -4.10 3,505 3,530 0.71
2017-08-11 13F-HR FT Options LLC Put 85,000 107,600 26.59 91 121 32.97
2018-08-14 13F-HR/A CITADEL ADVISORS LLC Call 0 14,500 0 343
2018-08-14 13F-HR HIGHLAND CAPITAL MANAGEMENT LP 20,000 0 -100.00 450 0 -100.00
2018-08-13 13F-HR Advisor Group, Inc. 45 45 0.00 1 1 0.00
2018-08-14 13F-HR D. E. Shaw & Co., Inc. 293,978 369,325 25.63 6,620 8,735 31.95
2018-08-14 13F-HR Alyeska Investment Group, L.P. 424,017 386,372 -8.88 9,549 9,138 -4.30
2018-08-14 13F-HR Botty Investors LLC 2,000 47
2018-08-14 13F-HR BOOTHBAY FUND MANAGEMENT, LLC Put 583 692 18.70 1,313 1,637 24.68
2018-08-14 13F-HR ROYAL BANK OF CANADA 107 607 467.29 2 14 600.00
2018-08-14 13F-HR BALYASNY ASSET MANAGEMENT LLC Put 220,000 5,203
2017-02-10 13F-HR BlackRock Advisors LLC 38,990 32,506 -16.63 566 430 -24.03
2018-04-18 13F-HR/A FNY Managed Accounts LLC 107 0 -100.00 3 0 -100.00
2018-08-14 13F-HR JP Morgan Chase & Co 218,794 264,470 20.88 4,928 6,255 26.93
2017-08-11 13F-HR FT Options LLC Call 61,500 70,000 13.82 152 141 -7.24
2018-08-14 13F-HR Foresite Capital Management II, LLC 967,636 967,636 0.00 21,791 22,885 5.02
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 1,547,283 1,562,321 0.97 22,467 20,670 -8.00
2018-08-14 13F-HR Cubist Systematic Strategies, LLC 0 8,468 0 200
2018-08-14 13F-HR Redmile Group, LLC 2,166,362 2,033,492 -6.13 48,786 48,092 -1.42
2018-02-14 13F-HR CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. 40,808 33,408 -18.13 1,272 1,041 -18.16
2018-08-08 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 381,444 400,130 4.90 8,591 9,464 10.16
2018-08-14 13F-HR GOLDMAN SACHS GROUP INC 345,433 428,775 24.13 7,779 10,140 30.35
2018-08-10 13F-HR CITIGROUP INC Put 10,200 8,300 -18.63 230 196 -14.78
2018-05-11 13F-HR CITIGROUP INC Put 35,700 10,200 -71.43 1,113 230 -79.34
2018-08-13 13F-HR Hudson Bay Capital Management LP 190,000 140,000 -26.32 4,279 3,311 -22.62
2018-08-10 13F-HR FEDERATED INVESTORS INC /PA/ 1,016 0 -100.00 23 0 -100.00
2018-08-14 13F-HR AQR CAPITAL MANAGEMENT LLC 99,003 99,003 0.00 2,230 2,341 4.98
INSM : Insmed Stock Analysis and Research Report

2017-10-30 - Asif

Insmed is a global biopharmaceutical company focused on the unmet needs of patients with rare diseases. Its lead product candidate is ARIKAYCE, or amikacin liposome inhalation suspension (ALIS) (formerly known as liposomal amikacin for inhalation, or LAI), which is in late-stage development for adult patients with treatment refractory nontuberculous mycobacteria (NTM) lung disease caused by Mycobacterium avium complex (MAC), a rare and often chronic infection that can cause irreversible lung damage and can be fatal. Its earlier clinical-stage pipeline includes INS1007 and INS1009. INS1007 is a novel oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1), an enzyme responsible for activating neutrophil serine proteases, which are implicated in the pathology of chronic inflammatory lung diseases, such as non-cystic fibrosis (non-CF) bronchiectasis. INS1009 is an inhaled nanoparticle formulation of a treprostinil prodrug that may offer a differentiated product profile for rare pulmon...

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Related News Stories

Major Biopharma Catalysts on September’s FDA Calendar

2018-09-08 247wallst
Biotech and pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to great, should a study come back negative or a candidate not be approved. Conversely, if a drug is approved or passes a clinical trial, there can be massive upside. (32-3)

Lilly, Teva, Pfizer & Others Await FDA Decisions in September

2018-09-07 zacks
Like 2017, 2018 is turning out to be a pretty good one for pharma and biotech stocks as far as FDA decisions are concerned. The regulatory body approved 34 novel drugs till August. Last year, the FDA had given nod to 31 new drugs till August and approved 46 drugs in the full year. (14-2)

Your Daily Pharma Scoop: Strongbridge And United Reports Positive, Insmed AdCom Favored

2018-08-12 seekingalpha
Discussion: Strongbridge Biopharma plc (SBBP) announced positive results from a Phase 3 clinical trial of RECORLEV (levoketoconazole) in patients with endogenous Cushing's syndrome. The open-label trial met the primary endpoint. The endpoint was a achievement of mean urinary free cortisol by a statistically valid proportion of patients. This patient group included people who were in a post-six months maintenance treatment without a dose increase of RECORLEV. (39-1)

Your Daily Pharma Scoop: Insmed's AdCom, Opko Progresses, Roche PRIMEd

2018-08-06 seekingalpha
Insmed up 7% premarket ahead of Ad Com review of inhalable amikacin for NTM lung disease (8-2)

Insmed, Inc. (INSM) CEO William Lewis on Q2 2018 Results - Earnings Call Transcript

2018-08-04 seekingalpha
Good day, ladies and gentlemen, and welcome to the Insmed Second Quarter 2018 Financial Results Conference Call. At this time, all phone participants are in a listen-only mode. [Operator Instructions] As a reminder, today's conference is being recorded. (1-0)

Insmed: Will ALIS Procure A Positive Regulatory Outcome?

2018-07-30 seekingalpha
Insmed is an innovator seeking to service the rare disease markets with high unmet needs. The stock enjoyed significant gains for the past year. However, there can be further upsides. (10-2)

Liquidia To File IPO - What Investors Need To Know

2018-07-02 seekingalpha
Liquidia Technologies (LQDA), has filed the necessary paperwork with the SEC to make an initial public offering. The biopharma company is seeking to raise at least $57 million and will trade on the NASDAQ Capital Market. Jefferies and Cowen will run the book on the IPO. (124-1)

Insmed: PDUFA Date Will Be A Game Changer

2018-06-04 seekingalpha
Insmed Inc. (NASDAQ:INSM) made a strong comeback from its April slump as the company announced the acceptance of its NDA. The stock received another boost from its strong results and positive corporate update. Insmed stock has shown strong momentum, which is likely to continue as the company awaits the FDA’s decision on its maiden drug. The company’s robust financial position, strong pipeline and liquidity position also indicate the high return potential of the stock. (19-0)

3 Things In Biotech, May 17: Insmed's Approval Chance, Pfizer Finally Proves Similar, Eagle Ascends

2018-05-18 seekingalpha
Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Try for free today and see what we're talking about! Here is some more information if you're curious. (25-1)

CUSIP: 457669307